Market Forecasts and Industry Analysis Human Vaccine Industry Key Enterprises- Beijing Ti

While the international enterprises have definite advantages in respects of high-end vaccines and multivalent vaccines, taking pneumococcal vaccines for instance, only one conjugate vaccine is available, say: Pneumococcal 7-Valent Conjugate Vaccine produced by Pfizer. Although, at present, several enterprises are conducting studies on pneumococcal conjugate vaccines, it is still long to launch on the market, with huge uncertainties. Request a Sample Copy of This Report @ https://www.radiantinsights.com/research/research-and-development-trend- forecast-of-china-touch-panel-market/request-sample In 2014-2018, the average growth rate of vaccine in China will maintain at 16%-18%. The main driving factors include: implement of national vaccine immunization plan, increasing receptivity of vaccine by people, rising trend of initiative vaccination and increase of type Ⅱvaccines application etc. It can be expected that the market scale of vaccine will hit CNY 40.5 billion in 2018. Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING Market definition • Market sizing 2016 • Market size and forecast 2016-2021 PART 06: FIVE FORCES ANALYSIS PART 07: MARKET SEGMENTATION BY APPLICATION • Segmentation by application • Comparison by application • Education - Market size and forecast 2016-2021 • Toy and hobby - Market size and forecast 2016-2021 • Market opportunity by application See More Reports of This Category by Radiant Insights @ https://www.radiantinsights.com/catalog/retail Follow Us:

Market Forecasts and Industry Analysis Human Vaccine Industry Key Enterprises- Beijing Ti | Page 2